Jim Simons
ABVC icon

Jim Simons’s ABVC BioPharma ABVC Stock Holding History

Jim Simons’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.3K Sell
95,100
-19,163
-17% -$31.7K ﹤0.01% 3042
2025
Q4 		$243K Buy
114,263
+3,763
+3% +$10.1K ﹤0.01% 2838
2025
Q3 		$336K Buy
110,500
+68,794
+165% +$211K ﹤0.01% 2958
2025
Q2 		$92.8K Buy
+41,706
New +$56.8K ﹤0.01% 3311
2024
Q1 		– Sell
-36,100
Closed -$42K – 3660
2023
Q4 		$42K Buy
+36,100
New +$42.6K ﹤0.01% 3479

Other funds holding ABVC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jim Simons's ABVC Position: Q1 2026 in Review

Jim Simons reduced its ABVC BioPharma (ABVC) stake by 17% in Q1 2026, selling an estimated $31.7K and leaving 95,100 shares worth $92.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

Jim Simons first reported a position in ABVC in Q4 2023 and has held it in 5 quarters since. The position peaked at $336K in Q3 2025. 13 funds tracked by Wall St. Rank hold ABVC as of Q1 2026.

  • Jim Simons held 95,100 shares of ABVC BioPharma worth $92.3K as of Q1 2026.
  • Jim Simons sold 19,163 ABVC BioPharma shares in Q1 2026, an estimated $31.7K.
  • ABVC BioPharma made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3042 holding.
  • Jim Simons first reported a position in ABVC BioPharma in Q4 2023 and has held it in 5 quarters since.
  • Jim Simons's ABVC BioPharma position peaked at $336K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held ABVC BioPharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.